RxDoctor Payments Data

John-Paul Rue, MD

Orthopaedic Surgery · Baltimore, MDNPI 1154308443

Payments from drug & device makers

$6,434in general payments, 2019–2025

Across 27 payments — averaging $238.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supreme Orthopedic Systems, LLC$6K
  • Nevro Corp.$169
  • Vericel Corporation$124
  • Stryker$83
  • Piedmont Plus Innovation$75
  • Convatec Inc.$34
  • plus $114 from 8 others

What the payments were for

  • Food & beverage$67010%
  • Education$5,76490%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Supreme Orthopedic Systems, LLC9$5,836
Nevro Corp.1$169
Vericel Corporation3$124
Stryker2$83
Piedmont Plus Innovation1$75
Convatec Inc.2$34
Lilly USA, LLC2$27
Native Surgical, LLC1$16
Novo Nordisk1$14
Acadia Pharmaceuticals Inc1$14
FX Shoulder Solutions, Inc1$13
Sanofi Pasteur Inc.1$12
Dynavax Technologies Corporation1$10
Electronic Waveform Lab, Inc.1$8

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,434 in reported general payments places this provider in the 60th percentile of 378 orthopaedic surgery providers in Maryland.

See all orthopaedic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$310,448
Medicare patients
492
Services billed
3,591

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →